 |
|
|
| |
PROTON: PSI-7977 & Peg/RBV in Treatment-naïve Patients with HCV GT1: Sustained Virologic Response
|
| |
| |
Reported by jules Levin
AASLD Nov 5-9 2011 SF
E Lawitz1, JP Lalezari2, T Hassanein3, KV Kowdley4, FF Poordad5, AM Sheikh6, NH Afdhal7, DE Bernstein8, E DeJesus9, B Freilich10, DR Nelson11, DT Dieterich12, IM Jacobson13,
D Jensen 14, GA Abrams15, JM Darling16, M Rodriguez-Torres17, KR Reddy18, MS Sulkowski19, NH Bzowej20, MP DeMicco21, JS Strohecker22, RH Hyland23, M Mader23,
R Hindes23, E Albanis23, WT Symonds23, MM Berrey23
1Alamo Medical Research, San Antonio, TX; 2Quest Clinical Research, San Francisco, CA; 3Southern California Liver Ctr, Coronado, CA; 4VMMC, Seattle, WA; 5Cedars Sinai Med Ctr, Los Angeles, CA; 6GI Specialists of Georgia, Marietta, GA; 7Beth Israel Deaconess, Boston, MA; 8North Shore University Hospital, Manhassett, NY; 9OIC, Orlando, FL; 10Kansas City Gastroenterology and Hepatology, LLCG, Kansas City, MO; 11University of Florida, Gainesville, FL; 12Mount Sinai, New York, NY; 13Cornell University, New York, NY;14University of Chicago, Chicago, IL; 15Alabama Liver and Digestive Specialists, Montgomery, AL;16University of North Carolina, Chapel Hill, NC;17Fundacion de Investigacion De Diego, San Juan, PR;18University of Pennsylvania, Philadelphia, PA;19Johns Hopkins University, Lutherville, MD;20California Pacific Medical Center, San Francisco, CA; 21ACRI, Anaheim, CA; 22Columbia Gastroenterology, Columbia, SC; 23Pharmasset, Inc., Princeton, NJ.
|
| |
|
|
|
|
|
